manage electrolyte abnormalities. 4 Other medical interventions include dietary phosphorus restriction, oral phosphate chelation, utilizing low-calcium dialysate solutions, and calcimimetics. Surgical interventions including local mass resection and parathyroidectomy have also been suggested, but neither strategy is curative in all patients. To date, the only curative option remains kidney transplant.
Most cases involve the shoulder, hip, and metatarsophalangeal joints; spinal cases are, overall, quite rare. 5 We report on a 73-year-old woman who was undergoing peritoneal dialysis and presented to the neurosurgical service with a neoplastic-appearing UTC lesion of the cervical spine.
case report
This 73-year-old woman had hypertension, obstructive sleep apnea, hypothyroidism, and a renal transplant for ESRD secondary to polycystic kidney disease. One year prior to presentation her transplant failed and she had to resume dialysis. She subsequently had a myocardial infarction and developed congestive heart failure. She underwent intermittent hemodialysis for 4 months and then transitioned to peritoneal dialysis. Two months after beginning peritoneal dialysis (referred to as the presentation date hereafter), the patient presented with a growing painful mass in the left posterolateral aspect of her neck.
An ultrasound examination performed 1 month after presentation (Fig. 1 ) demonstrated a 2.1 × 1.4 × 2.6-cm hypoechoic, avascular lesion located 1 cm deep to the skin within the posterior triangle of the neck. A follow-up CT scan performed 3 months after presentation ( Fig. 2A and D) revealed an enlarged 2.9 × 2.3 × 2.2-cm calcified, multilobular, and peripherally corticated mass in the paraspinal soft tissues adjacent to the left C2-3 facet joint. There was also extension into the left C2-3 intervertebral foramen. A bone scan (Fig. 3) ). Throughout, the patient denied radicular pain and was neurologically intact on detailed examination. Resection of this growing lesion, for diagnosis and potential tumor control, was deferred until her medical status could be optimized, given her significant comorbidities. In the interim, hemodialysis was initiated, and a follow-up CT scan was performed 10 months after presentation ( Fig. 2B and E). This CT scan showed an unexpected decrease in the size of the lesion (to 2.4 × 1.7 × 1.8 cm). Repeat blood tests confirmed ongoing uremia (14.6 mmol/L) but showed normalization of the calcium-phosphate product (3.41 mmol 2 / L 2 ). Given this finding, the decision was made to continue monitoring the patient's clinical condition. Her neck pain decreased over time. At the time of this writing, the patient continues to receive hemodialysis, her neck pain has resolved, and she has had no other symptoms related to the lesion. A CT scan performed at 17 months after presentation demonstrated continued decrease in the size of the lesion (Fig. 2C and F) .
literature review
A thorough search of the PubMed and EMBASE databases was completed on May 24, 2015, and citations from previous case reports were also reviewed. 12, 19 The search was limited to native and translated English-language articles. A PRISMA flow diagram (Fig. 4) outlines the systematic review.
Thirty-three potentially relevant references were identified on the basis of the MeSH keywords ("tumoral calcinosis" or "dialysis related calcinosis") and "cervical spine." An additional 2 cases were added from citation lists. Fourteen duplicated results were removed and an additional 14 articles were excluded because they did not involve patients with uremia. Ultimately, 7 cases of UTC in the cervical spine were identified; these cases are summarized in Table 1 .
Discussion
Uremic tumoral calcinosis (UTC) is a rare phenomenon affecting 0.5%-3% of patients with renal failure. 4, 19, 20 In this disease, calcium-phosphate salts precipitate in the periarticular soft tissues surrounding weight-bearing or overused joints including spinal facet joints. A review of the English literature yielded 7 cases of UTC affecting the cervical spine; in 6 of these cases the patients were undergoing hemodialysis, and in 1 case the patient was undergoing peritoneal dialysis. In this limited sample, disproportionately more female patients were affected (5 female, 2 male).
The etiology of this disease is not fully understood, but systemic factors, genetic factors, and local conditions have been implicated. The most important systemic factor is hyperphosphatemia, which was reported in nearly all patients regardless of serum calcium levels. 4, 19, 20 Local conditions that have been implicated in the stimulation of calcium salt deposition include trauma, hematomas, and de novo overproduction of calcifiable matrix protein. Other possible predisposing factors are genetic mutations in the FGF23 and GALNT3 genes, leading to a decrease in the level of functional fibroblast growth factors, which is associated with hyperphosphatemic tumoral calcinosis. 1, 8, 15 In the spine, the differential diagnosis of a growing, calcified, paraspinal mass commonly includes sarcomas, primary osteochondral tumors, infection, and myositis ossificans. We stress the importance of including UTC in the differential diagnosis when managing a patient who may have an underlying metabolic disturbance. 9 The cornerstone of medical therapy is correcting the underlying calcium and phosphate elevations. The 2005
Caring for Australasians with Renal Impairment (CARI) guidelines suggest achieving an albumin-corrected calcium-phosphate product of less than 4 mmol/L to minimize the risk of aberrant calcification (Level III evidence).
7 To achieve this goal, many patients are treated with aggressive phosphate binders, calcimimetics, dietary phosphorus restriction, oral chelation, and increased length and frequency of hemodialysis treatments. 19 Surgical approaches include both parathyroidectomy and local resection of masses. Two studies have reported performing parathyroidectomy in patients with severe hyperparathyroidism and hypercalcemia refractory to medical treatment. 4, 19, 20 Resection is generally undertaken for lesions causing acute, progressive, or refractory neurological dysfunction. Surgery is also indicated where severe pain and functional limitation are attributable to the lesion. In a recent report of UTC causing atlantoaxial subluxation and limited range of motion due to pain, Chang et al. describe lesion resection and fusion resulting in satisfactory pain relief and functional improvement. 3 In the subset of patients with tumoral calcinosis and continued metabolic disturbances, a recurrence rate of 33% has been reported. 10 Other studies have suggested that incomplete resection is associated with higher rates of recurrence. 11, 14, 17 conclusions UTC may involve the cervical spine, causing pain and radiologically mimicking an osteoblastic neoplasm. Our patient might have undergone a surgical intervention had her significant medical comorbidities not led to initial conservative management. As her metabolic abnormalities resolved, the calcified mass significantly decreased in size. Consistent with previous reports, control of serum phosphate and calcium-phosphate product levels remains the cornerstone of preventing UTC. The unique presentation in this report highlights the importance of including UTC in the differential diagnosis of bone-forming lesions in patients with ESRD. 
